Edition:
India

People: CRISPR Therapeutics AG (CRSP.OQ)

CRSP.OQ on NASDAQ Stock Exchange Global Market

68.46USD
19 Nov 2019
Change (% chg)

$0.00 (+0.00%)
Prev Close
$68.46
Open
--
Day's High
--
Day's Low
--
Volume
247
Avg. Vol
171,836
52-wk High
$73.99
52-wk Low
$22.23

George, Simeon 

Dr. Simeon J. George, M.D. is Independent Director of CRISPR Therapeutics Ltd. Dr. George currently serves as a Partner at S.R. One, Limited, where he has been employed since 2007. In addition, Dr. George previously served as a director on the boards of the following biotechnology companies: Semprus BioSciences Corp. (acquired by Teleflex Incorporated in June 2012) from December 2010 to June 2012, HTG Molecular Diagnostics, Inc. from June 2011 to October 2015, and Genocea Biosciences, Inc. from July 2010 to December 2014. Dr. George also served as a consultant at Bain & Company from October 2006 to August 2007. Dr. George received an M.D. from the University of Pennsylvania School of Medicine, an M.B.A. from the Wharton School of the University of Pennsylvania, and a B.A. in Neuroscience from Johns Hopkins University. We believe Dr. George’s experience in the biopharmaceutical industry, as well as his experience as a member on the boards of directors of multiple companies in the industry, qualifies him to serve on our Board of Directors.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Rodger Novak

645,572

Samarth Kulkarni

9,727,530

Michael Tomsicek

2,253,360

Tony Ho

4,149,120

James Kasinger

3,160,750

Lawrence Klein

--
As Of  31 Dec 2018